Published in J Am Coll Surg on September 01, 1995
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Treatment of metastatic melanoma: an overview. Oncology (Williston Park) (2009) 4.58
Increasing burden of melanoma in the United States. J Invest Dermatol (2009) 4.43
Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum Mol Genet (2013) 1.95
Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. Am J Pathol (1999) 1.80
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. Ophthalmology (2009) 1.78
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer (2005) 1.68
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430. Cancer (2011) 1.66
Melanoma genetics and the development of rational therapeutics. J Clin Invest (2005) 1.50
Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors. J Oncol (2012) 1.44
Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol (2011) 1.29
RNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway. PLoS One (2009) 1.28
Post-embryonic nerve-associated precursors to adult pigment cells: genetic requirements and dynamics of morphogenesis and differentiation. PLoS Genet (2011) 1.28
A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1). Cancer (2010) 1.22
Improved survival for stage IV melanoma from an unknown primary site. J Clin Oncol (2009) 1.18
Characteristics and management of immunerelated adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma. Cancer Manag Res (2012) 1.08
Surgery for distant melanoma metastasis. Cancer J (2012) 1.03
PD-1 pathway inhibitors: the next generation of immunotherapy for advanced melanoma. Oncotarget (2015) 1.02
Decoding melanoma metastasis. Cancers (Basel) (2010) 1.02
A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. Br J Cancer (2004) 1.01
Staging and prognosis of cutaneous melanoma. Surg Oncol Clin N Am (2011) 0.98
Pathogenesis, diagnosis and management of primary melanoma of the colon. World J Surg Oncol (2011) 0.98
Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma. J Natl Cancer Inst (2004) 0.97
A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: a phase 2 consortium study. Cancer (2010) 0.95
Synthesis and antiproliferative activity of imidazole and imidazoline analogs for melanoma. Bioorg Med Chem Lett (2008) 0.95
Checkpoint modulation in melanoma: an update on ipilimumab and future directions. Curr Oncol Rep (2013) 0.94
Long-term survival in patients with metastatic melanoma treated with DTIC or temozolomide. Oncologist (2010) 0.92
The efficacy of anti-PD-1 agents in acral and mucosal melanoma. Cancer (2016) 0.92
Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis. Ann Oncol (2012) 0.92
Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B. Eur J Nucl Med Mol Imaging (2008) 0.91
Augmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4. Cancer Res (2012) 0.90
Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer. Br J Cancer (2002) 0.90
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial. Invest New Drugs (2010) 0.90
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma. Ann Surg (2012) 0.89
Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma. Br J Cancer (2011) 0.88
Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation. Cancer Manag Res (2012) 0.88
New treatments for metastatic melanoma. CMAJ (2014) 0.87
Rare clinical experiences for surgical treatment of melanoma with osseous metastases in Taiwan. BMC Musculoskelet Disord (2007) 0.87
Molecular clonality of in-transit melanoma metastasis. Am J Pathol (2001) 0.86
Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma. J Immunother (2015) 0.86
Imaging tumour cell heterogeneity following cell transplantation into optically clear immune-deficient zebrafish. Nat Commun (2016) 0.85
MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603. Clin Epigenetics (2015) 0.84
Biological factors, tumor growth kinetics, and survival after metastasectomy for pulmonary melanoma. Ann Surg Oncol (2009) 0.84
A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases. World J Surg Oncol (2012) 0.83
Nodular melanoma presenting with rapid progression and widespread metastases: a case report. J Med Case Rep (2009) 0.82
Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours. Br J Cancer (2011) 0.82
Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV. Contemp Oncol (Pozn) (2013) 0.82
The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma. Support Care Cancer (2003) 0.82
Melanoma biomarkers: Vox clamantis in deserto (Review). Oncol Lett (2010) 0.81
Latest developments in the treatment of melanoma: 'a penicillin moment for cancer'? J R Soc Med (2011) 0.80
Surgery and adjuvant therapies in the treatment of stage IV melanoma: our experience in 84 patients. Langenbecks Arch Surg (2008) 0.80
Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma. Br J Cancer (2010) 0.79
Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma. World J Surg Oncol (2012) 0.79
Retrospective Study of Metastatic Melanoma and Renal Cell Carcinoma to the Brain with Multivariate Analysis of Prognostic Pre-Treatment Clinical Factors. Int J Mol Sci (2016) 0.78
Contemporary approaches for imaging skeletal metastasis. Bone Res (2015) 0.78
Solitary secondary malignant melanoma of clavicle two years after enuclation for ocular melanoma. Case Rep Orthop (2013) 0.78
Quercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development Strategy. Front Nutr (2016) 0.78
New developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapy. Drug Healthc Patient Saf (2014) 0.77
A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma. J Cancer Res Clin Oncol (2006) 0.77
Clinical utility of serum autoantibodies detected by protein microarray in melanoma. Int J Proteomics (2011) 0.77
Metastatic Melanoma in the Femur - Case Report with Review of Literature: a Pathologist's Point of View. Maedica (Buchar) (2014) 0.77
Prognosis of patients with advanced melanoma. J Am Coll Surg (1995) 0.76
Adipogenic niches for melanoma cell colonization and growth in bone marrow. Lab Invest (2017) 0.75
Treatment outcomes of advanced stage malignant melanoma in hand and foot after amputation in Korean patients. Clin Orthop Surg (2013) 0.75
Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis. PLoS One (2017) 0.75
Two cases of partial hepatectomy for malignant melanoma. Hawaii J Med Public Health (2012) 0.75
Immature mediastinal teratoma with unusual histopathology: A case report of multi-lineage, somatic-type malignant transformation and a review of the literature. Medicine (Baltimore) (2016) 0.75
Combined dabrafenib and trametinib therapy in metastatic melanoma and organ transplantation: Case report and review of the literature. JAAD Case Rep (2015) 0.75
Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy. Eur J Nucl Med Mol Imaging (2007) 0.75
Operative management of metastatic melanoma in bone may require en bloc resection of disease. Clin Orthop Relat Res (2014) 0.75
Bcl-2 expression is not associated with survival in metastatic cutaneous melanoma: a historical cohort study. World J Surg Oncol (2008) 0.75
Prostate metastasis of malignant melanoma. Korean J Urol (2013) 0.75
A particularly bothersome umbilical nodule. Indian J Dermatol (2013) 0.75
Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review. Oncol Lett (2015) 0.75
Single sternal metastasis due to malignant melanoma with unexpected long-term survival: a case report. Onco Targets Ther (2016) 0.75
Scalp junctional nevus with malignant transformation (melanoma) metastatic to parotid lymph node region, cervical lymph nodes and the back: a case report and review of literature. Int J Clin Exp Pathol (2015) 0.75
Surgical resection plus biotherapy/chemotherapy improves survival of hepatic metastatic melanoma. World J Hepatol (2012) 0.75
Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study. Oncol Lett (2016) 0.75
Biology of human cutaneous melanoma. Cancers (Basel) (2010) 0.75
[New aspects for staging and grading of tumor metastases]. Pathologe (2015) 0.75
Video capsule endoscopy to diagnose metastatic melanoma. Dig Dis Sci (2007) 0.75
Mycobacterium bovis Bacillus Calmette-Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function. Front Immunol (2017) 0.75
Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma. Oncologist (2017) 0.75
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg (1994) 8.85
Impaired immunologic reactivity and recurrence following cancer surgery. Cancer (1970) 3.77
Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg (1995) 3.62
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56
IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol (1989) 2.86
Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry (1993) 2.38
Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol (1988) 2.32
BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14
Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol (1999) 2.08
Parathyroid carcinoma: a collective review. Ann Surg (1969) 1.94
Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg (1996) 1.91
The nature of immune complexes in human cancer sera. J Immunol (1977) 1.88
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Complications of BCG immunotherapy in patients with cancer. N Engl J Med (1973) 1.72
Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol (1998) 1.71
Radiofrequency ablation: a minimally invasive technique with multiple applications. Cancer J Sci Am (1999) 1.70
Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann Surg (1970) 1.68
Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol (1995) 1.66
Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences? Ann Surg Oncol (2000) 1.64
Long-term survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol (1999) 1.63
Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line. J Exp Med (1989) 1.62
Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma? Ann Surg Oncol (2000) 1.59
Human osteosarcomas: immunologic evidence suggesting an associated infectious agent. Science (1968) 1.58
Detection of antibody and complement complexed in vivo on membranes of human cancer cells by mixed hemadsorption techniques. Cancer Res (1975) 1.58
Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N Engl J Med (1976) 1.57
Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol (2001) 1.57
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg (1992) 1.50
Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol (2001) 1.48
Parotid region lymphatic mapping and sentinel lymphadenectomy for cutaneous melanoma. Ann Surg Oncol (1999) 1.47
Is amputation necessary for sarcomas? A seven-year experience with limb salvage. Ann Surg (1980) 1.46
Current management of malignant melanoma. Ann Surg (1990) 1.43
Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas? Ann Surg Oncol (2000) 1.43
Hepatic resection of metastatic colorectal carcinoma: a ten-year experience. Arch Surg (1982) 1.43
Human liposarcomas: tissue cultures containing foci of transformed cells with viral particles. Science (1969) 1.42
Serum TA90 antigen-antibody complex as a surrogate marker for the efficacy of a polyvalent allogeneic whole-cell vaccine (CancerVax) in melanoma. Ann Surg Oncol (2001) 1.42
Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol (1998) 1.41
Role of percutaneous fine-needle aspiration biopsy in suspected intrathoracic malignancy. Ann Thorac Surg (1991) 1.40
Retroperitoneal sarcomas: a reappraisal of treatment. J Surg Oncol (1981) 1.40
Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res (2000) 1.38
Granulomatous hepatitis: a complication of B.C.G. immunotherapy. Lancet (1973) 1.38
Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival. Ann Surg Oncol (1999) 1.38
Will the true sentinel node please stand? Ann Surg Oncol (1999) 1.35
Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res (1997) 1.35
Neurofibrosarcoma. Cancer (1980) 1.33
Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am (1999) 1.30
Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J Natl Cancer Inst (1981) 1.30
Advances in the treatment of sarcomas of the extremity. Current status of limb salvage. Cancer (1984) 1.28
Immunologic studies of human sarcomas: Additional evidence suggesting an associated sarcoma virus. Cancer (1970) 1.27
Correlation of in vivo and in vitro assays of immunocompetence in cancer patients. Cancer Res (1974) 1.27
Clinical aspects of unknown primary melanoma. Ann Surg (1980) 1.27
Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg (1991) 1.27
Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol (1999) 1.27
Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol (2001) 1.26
Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum. J Natl Cancer Inst (1974) 1.23
Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol (1999) 1.22
Pulmonary resection for metastatic sarcoma. Am J Surg (1980) 1.22
Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol (1982) 1.20
Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer (2001) 1.19
A membrane antigen common to human cancer and fetal brain tissues. Cancer Res (1976) 1.19
Metastasectomy for recurrent stage IV melanoma. J Surg Oncol (1999) 1.18
Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg (2000) 1.18
Immunologic abnormalities in head and neck cancer. Am J Surg (1974) 1.17
Gangliosides of human melanoma. J Natl Cancer Inst (1987) 1.17
Cell-mediated immunity is depressed following cardiopulmonary bypass. Ann Thorac Surg (1981) 1.16
Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg (1982) 1.15
The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer (2000) 1.15
Evidence for in vivo reaction of antibody and complement to surface antigens of human cancer cells. Science (1974) 1.15
Lack of correlation between skin reactivity to dinitrochlorobenzene and croton oil in patients with cancer. N Engl J Med (1975) 1.14
Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg (2001) 1.14
Prognostic significance of tumor doubling time in evaluating operability in pulmonary metastatic disease. J Thorac Cardiovasc Surg (1971) 1.14
Functional RET G691S polymorphism in cutaneous malignant melanoma. Oncogene (2009) 1.14
Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients. Cancer Res (1999) 1.14
Immunologic and virus studies with human sarcomas. Surgery (1969) 1.13
Natural history of surgically treated mucosal melanoma. Am J Surg (1987) 1.13
Nodal nevi and cutaneous melanomas. Am J Surg Pathol (1996) 1.13
Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg (1995) 1.13
Limb salvage for skeletal and soft tissue sarcomas. Multidisciplinary preoperative therapy. Cancer (1984) 1.12
Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res (1998) 1.12
Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning. Surg Forum (1977) 1.11
Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Am J Pathol (1997) 1.11
Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery (1999) 1.10
Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol (2001) 1.10
Immunogenicity of melanoma-associated gangliosides in cancer patients. Int J Cancer (1985) 1.10
Sequential evaluation of general immune competence in cancer patients: correlation with clinical course. Cancer (1975) 1.09
Normal tissue and solid tumor effects of hyperthermia in animal models and clinical trials. Cancer Res (1979) 1.09
Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay. Cancer Res (1984) 1.09
Immunological studies with human neoplasms. J Reticuloendothel Soc (1971) 1.08
Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res (1982) 1.08
Regional lymph node metastases and the level of invasion of primary melanoma. Cancer (1976) 1.08
Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms. Arch Surg (2000) 1.07
Thermochemotherapy for melanoma metastases in liver. Cancer (1982) 1.07